Pan African Resources PLC (PAF)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 111.30 |
|---|---|
| 52-week range | 76.50 – 190.40 |
| Return, 1 month / 3 months | −14.3% / +15.8% |
| Return, 1 year / 3 years | +33.6% / +646.8% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 58.4% |
| Worst drawdown (1 year) | -51.5% |
| Average daily value traded | 816.94M GBX |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Pan African Resources is a gold mining company based in South Africa. It operates underground and surface gold mines and tailings retreatment plants, recovering gold from both fresh ore and material left over from earlier mining. Its operations are located in the country's historic gold regions, and it produces gold doré bars for refining and onward sale to precious metals markets. The company's activities span mining, processing and the recovery of gold from waste material at its sites.
Pan African Resources PLC trades under the code PAF on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Pan African Resources PLC (PAF) trades on the London Exchange in UK. It last closed at GBX 111.30 on 22 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 2,225 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.6% and over the last three months it rose 15.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 25 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.4% | ||
| From 52-week high | -39.3% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 15.8% | ||
| 6-month return | -27.9% | ||
| 12-month return, skipping the last month | 55.8% | ||
| Stability (higher is calmer) | 20 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 58.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -51.5% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 816.94M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −5.7% |
|---|---|
| 1 month | −14.3% |
| 3 months | +15.8% |
| 6 months | −27.9% |
| 1 year | +33.6% |
| 3 years | +646.8% |
| 5 years | +680.6% |
Signals
| 50-day / 200-day average | 123.24 / 128.46 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Mar 2026 | GBP 0.0055 |
| 27 Nov 2025 | GBP 0.0164 |
| 28 Nov 2024 | GBP 0.0096 |
| 30 Nov 2023 | GBP 0.0076 |
| 1 Dec 2022 | GBP 0.0087 |
| 2 Dec 2021 | GBP 0.0085 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.